Kristin Alfaro-Munoz

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

K. Alfaro-Munoz, K.D. Alfaro-Munoz, Kenneth Aldape, Kristin Alfaro-Munoz, Kristin D Alfaro-Munoz, Kristin D. Alfaro, Kristin D. Alfaro-Munoz, Michael Weller

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Baylor College of Medicine Jackson Laboratory Medical University of South Carolina

About

Kristin Alfaro-Munoz is an author at The University of Texas MD Anderson Cancer Center specializing in glioma, neuro-oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	639
2	Health Sciences	3	3	58
3	Neurology	3	3	242
4	Immunology	2	2	53
5	Cell Biology	1	1	33

Kristin Alfaro-Munoz

Publications

Citations

H-Index

Page 1

	Year	Citations
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas Adriana Olar, Khalida Wani, Kristin Alfaro-Munoz, Acta Neuropathologica Tumor BiologyNeuro-oncologyTumoral PathologyOverall SurvivalTumor Heterogeneity	2015	345
The molecular landscape of glioma in patients with Neurofibromatosis 1 Fulvio D’Angelo, Michele Ceccarelli, Tala, Nature Medicine Neuro-oncologyTumor HeterogeneityNeurofibromatosis 1PathologyBrain Tumor Biology	2018	203
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages John de Groot, Marta Peñas-Prado, Kristin Alfaro-Munoz, Neuro-Oncology	2019	158
DNA copy number analysis of Grade II–III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status Adam L. Cohen, Mariko Sato, Kenneth Aldape, Acta Neuropathologica Communications	2015	82
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, npj Precision Oncology	2024	75
Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells Sabbir Khan, Rajasekaran Mahalingam, Shayak Sen, Cancers ImmunologyCell DeathCancer BiologyGliomaTumor Biology	2021	33
Prospective Clinical Sequencing of Adult Glioma Siyuan Zheng, Kristin Alfaro-Munoz, Wei Wei, Molecular Cancer Therapeutics	2019	21
Pre-surgical connectome features predict IDH status in diffuse gliomas Shelli R. Kesler, Rebecca A. Harrison, Melissa Petersen, Oncotarget	2019	21
Window-of-opportunity clinical trial of a PD-1 inhibitor in patients with recurrent glioblastoma. John Frederick De Groot, Marta Peñas-Prado, Jacob Mandel, Journal of Clinical Oncology Window-of-opportunity Clinical TrialImmunologyImmunotherapeuticsRecurrent GlioblastomaImmunotherapy	2018	20
Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients David Cachia, Nabil Elshafeey, Carlos Kamiya-Matsuoka, Journal of Neuro-Oncology Neuro-oncologyOncologic ImagingMedicineGlioblastoma PatientsNeurology	2017	19

Page 1